Literature DB >> 35838883

Effect of Human Cytochrome P450 2D6 Polymorphism on Progesterone Hydroxylation.

Toshiro Niwa1, Shoko Sasaki2, Yuka Yamamoto2, Mayu Tanaka2.   

Abstract

BACKGROUND AND OBJECTIVES: Herein, hydroxylation activities at the 6β-position and 21-position of progesterone mediated by human cytochrome P450 (CYP) 2D6 and its variants and the effects of psychotropic drugs on these hydroxylation activities were compared to clarify whether CYP2D6 polymorphisms and psychotropic drugs impact neurosteroid levels in the brain.
METHODS: Progesterone was incubated with CYP2D6.1, CYP2D6.2 (Arg296Cys, Ser486Thr), CYP2D6.10 (Pro34Ser, Ser486Thr), and CYP2D6.39 (Ser486Thr) in the absence or presence of typical psychotropic drugs (fluvoxamine, fluoxetine, paroxetine, fluphenazine, and milnacipran) and endogenous steroids (testosterone and cortisol). Then, 6β- and 21-hydroxyprogesterone levels were determined by high-performance liquid chromatography.
RESULTS: Although the Michaelis-Menten constants (Km) for progesterone 6β- and 21-hydroxylation reactions mediated by the different CYP2D6 variants were similar, the maximal velocity (Vmax) values of the reactions mediated by CYP2D6.1 and CYP2D6.2 were the highest, followed by those mediated by CYP2D6.39 and CYP2D6.10. Thus, the of progesterone 6β- and/or 21-hydroxylation reactions mediated by CYP2D6.1 and CYP2D6.2 showed the highest Vmax/Km values, followed by the reactions mediated by CYP2D6.39. All investigated compounds inhibited progesterone 21-hydroxylation mediated by CYP2D6 variants at high concentrations. Interestingly, at low concentrations, fluoxetine increased progesterone 21-hydroxylation mediated by CYP2D6.1, but not that mediated by CYP2D6.2 or CYP2D6.10. In addition, the Km value for CYP2D6.2 was elevated in the presence of fluoxetine, whereas the value for CYP2D6.1 was unaltered; however, Vmax values of both CYP2D6.1 and CYP2D6.2 were increased. Paroxetine competitively inhibited CYP2D6.1- and CYP2D6.2-mediated progesterone 21-hydroxylation.
CONCLUSIONS: These results suggest that CYP2D6 polymorphism can affect the stimulation/inhibition of progesterone 21-hydroxylation.
© 2022. The Author(s), under exclusive licence to Springer Nature Switzerland AG.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35838883     DOI: 10.1007/s13318-022-00784-7

Source DB:  PubMed          Journal:  Eur J Drug Metab Pharmacokinet        ISSN: 0378-7966            Impact factor:   2.569


  25 in total

1.  CYP2D in the brain.

Authors:  Yoshihiko Funae; Wataru Kishimoto; Toshio Cho; Toshiro Niwa; Toyoko Hiroi
Journal:  Drug Metab Pharmacokinet       Date:  2003       Impact factor: 3.614

2.  Polymorphism of the cytochrome P450 CYP2D6 gene in a European population: characterization of 48 mutations and 53 alleles, their frequencies and evolution.

Authors:  D Marez; M Legrand; N Sabbagh; J M Lo Guidice; C Spire; J J Lafitte; U A Meyer; F Broly
Journal:  Pharmacogenetics       Date:  1997-06

3.  Debrisoquine hydroxylation polymorphism and personality.

Authors:  L Bertilsson; C Alm; C De Las Carreras; J Widen; G Edman; D Schalling
Journal:  Lancet       Date:  1989-03-11       Impact factor: 79.321

Review 4.  Summary of information on human CYP enzymes: human P450 metabolism data.

Authors:  Slobodan Rendic
Journal:  Drug Metab Rev       Date:  2002 Feb-May       Impact factor: 4.518

Review 5.  Comparison of cytochrome P450 2D6 and variants in terms of drug oxidation rates and substrate inhibition.

Authors:  Toshiro Niwa; Norie Murayama; Hiroshi Yamazaki
Journal:  Curr Drug Metab       Date:  2011-06       Impact factor: 3.731

Review 6.  Progesterone as a neurosteroid: synthesis and actions in rat glial cells.

Authors:  I Jung-Testas; A Do Thi; H Koenig; F Désarnaud; K Shazand; M Schumacher; E E Baulieu
Journal:  J Steroid Biochem Mol Biol       Date:  1999 Apr-Jun       Impact factor: 4.292

Review 7.  Regioselective hydroxylation of steroid hormones by human cytochromes P450.

Authors:  Toshiro Niwa; Norie Murayama; Yurie Imagawa; Hiroshi Yamazaki
Journal:  Drug Metab Rev       Date:  2015-02-13       Impact factor: 4.518

8.  Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians.

Authors:  T Shimada; H Yamazaki; M Mimura; Y Inui; F P Guengerich
Journal:  J Pharmacol Exp Ther       Date:  1994-07       Impact factor: 4.030

Review 9.  Drug-drug interactions for UDP-glucuronosyltransferase substrates: a pharmacokinetic explanation for typically observed low exposure (AUCi/AUC) ratios.

Authors:  J Andrew Williams; Ruth Hyland; Barry C Jones; Dennis A Smith; Susan Hurst; Theunis C Goosen; Vincent Peterkin; Jeffrey R Koup; Simon E Ball
Journal:  Drug Metab Dispos       Date:  2004-08-10       Impact factor: 3.922

Review 10.  Neurosteroids: a novel function of the brain.

Authors:  E E Baulieu
Journal:  Psychoneuroendocrinology       Date:  1998-11       Impact factor: 4.905

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.